EP Wealth Advisors LLC acquired a new stake in Merck KGaA (OTCMKTS:MKGAF - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 282,377 shares of the company's stock, valued at approximately $36,285,000. EP Wealth Advisors LLC owned approximately 0.22% of Merck KGaA at the end of the most recent reporting period.
Other hedge funds also recently added to or reduced their stakes in the company. Danske Bank A S bought a new position in Merck KGaA during the 2nd quarter worth about $276,535,000. Great Lakes Advisors LLC purchased a new position in Merck KGaA during the 2nd quarter valued at about $183,444,000. Ieq Capital LLC bought a new stake in shares of Merck KGaA in the 2nd quarter valued at about $102,699,000. Tocqueville Asset Management L.P. bought a new stake in shares of Merck KGaA in the 2nd quarter valued at about $57,546,000. Finally, B. Metzler seel. Sohn & Co. AG purchased a new stake in shares of Merck KGaA in the 2nd quarter worth approximately $56,952,000. 0.10% of the stock is owned by hedge funds and other institutional investors.
Merck KGaA Price Performance
OTCMKTS MKGAF opened at $163.21 on Friday. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. The firm's 50 day moving average price is $162.62 and its 200-day moving average price is $148.46. Merck KGaA has a 52-week low of $116.68 and a 52-week high of $175.56. The company has a market cap of $21.09 billion, a PE ratio of 24.92 and a beta of 0.96.
Merck KGaA Company Profile
(
Free Report)
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company's operations are organized mainly into three businesses.
Recommended Stories
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Merck KGaA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merck KGaA wasn't on the list.
While Merck KGaA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
